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The ability of some hydrogenated vegetable oils to act as dry binder in direct compression 
tablet formulations was investigated using an instr umented rotary tablet press. The effect of 
these widely used tablet lubricants was compared to  Avicel ® PH 102, a standard, dry binding 
excipient in direct compression tablet formulations . The effects of the hydrogenated vegetable 
oils on the hardness, friability, disintegration ti me and dissolution of tablets made from the 
direct compression tablet formulations were evaluat ed. Dika fat, Lubritab ®, Sterotex ®, 
Stearolac-S ® and stearic acid improved the hardness and friabil ity profiles of a model direct 
compression tablet formulation as well as ascorbic acid and aspirin-acetaminophen tablet 
formulations. Prolonged mixing had no deleterious e ffect on the properties of the 
hydrochlorothiazide, ascorbic acid and aspirin-para cetamol tablets prepared. The 
hydrogenated vegetable oils appear to be a good alt ernative to Avicel ® PH 102 as dry binder in 
the formulations evaluated. 
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In pharmaceutical tabletting technology, 
hydrogenated vegetable oils are used as 
lubricants, and are made from fully 
hydrogenated refined vegetable oils that are 
sprayed onto dry, fine powder (Edward 
Mendell Co. Inc., USA, 1982). They are 
specifically created for application in the 
production of pharmaceutical tablets. 
Generally, they are used as lubricants in the 
range of 1 – 5% w/w (Shangraw, 1985) and as 
auxiliary dry binder when tablets and capsules 
tend to cap and laminate (Edward Mendell Co. 
Inc., USA, 1982). Used as dry binder, addition 
of up to 5 - 10% w/w can eliminate these 
problems and aid in producing satisfactory 
tablets. They are most effective when added in 
the dry state in the last blending operation 
before compression and mixed for 10 – 15 
minutes (Edward Mendell Co. Inc., USA, 
1982). When using hydrogenated vegetable 
oils as auxiliary binders, it is important that 
their effect on the tablet properties of 
hardness, friability, disintegration and 
dissolution be ascertained. 
The objective of the present 
investigation was to evaluate the potential 
application of some hydrogenated vegetable 
oils as auxilliary dry binders in direct 
compression tabletting. The effects of the fats 
(Dika fat, Lubritab®, Sterotex®, Stearolac-S®  
and  stearic acid) on the hardness, friability, 
disintegration time and dissolution rate of 
tablets made from three direct compression 
tablet formulations were compared to those of 
tablets containing Avicel® PH 102, a widely 
used auxilliary dry binder.  
 
Materials and Methods 
 
Dika fat was obtained from Irvingia gabonensis 
by soxhlet extraction as previously described 
(Onyechi, 1987). The fat was further purified, 
bleached and deodorized by standard 
techniques (Onyechi, 1987).  
Lubritab® (Edward Mendell Co. Inc., 
USA), Sterotex® (Capitol City Products, USA), 
Stearolac-S® (Paniplus Coy., USA) and stearic 
acid (Baker Co., USA) were used as received 
from the manufacturers. The other excipients 
used were unmilled dicalcium phosphate, 
Ditab ® (Stauffer Chemical Coy., USA), 
hydrous lactose, Fast Flo ®Lactose (Foremost 
Foods, USA), compressible sugar, Dipac ® 
(Amstar, USA), Sta-Rx®1500 (A.E. Staley Co., 
USA), colloidal fumed silicon dioxide, Cab-O-
Sil® (Carbot Corp., USA) and magnesium 
stearate (Amend Drug and Chem. Co., USA). 
The drugs aspirin granules (Monsanto 
Chemical Co., USA), ascorbic acid (Roche, 
US), paracetamol granules (Mallinckrodt, 
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USA), hydrochlorothiazide (Industria Chimica, 
Italy) were used as received from their 
manufacturers.   
   
Blending and lubrication of powder 
mixtures: In all the formulations (Table 1), 
drugs and excipients with no dry binders 
added were preblended for 5 min in a twin 
shell blender (Model LB-3794, Patterson Kelly 
Co., PA, USA).  Calculated quantities of the 
dry binders were then added after being 
passed through a 250 µm aperture sieve.  
Blending was then continued for 5, 10 and 30 
min respectively for the model direct 
compression formulation.  The aspirin-
acetaminophen, ascorbic acid and 
hydrochlorothiazide tablet formulations were 




Dika fat at a range of 1 - 5 and 10% w/w 
concentration levels were used in all the 
formulations.  Tablet properties evaluated 
were hardness, friability, disintegration time 
and dissolution rate.  Other dry binders used 
as basis for comparison were Avicel® PH 102 
and the hydrogenated vegetable oils Sterotex® 
, Lubritab®, Stearolac-S® and stearic acid 
 
Instrumentation of rotary tablet press: A 
Stokes model RB-2 rotary tablet press (Stokes 
Engineering Philadelphia, PA, USA) which 
was instrumented as described previously 
(Salpekar and Augsburger, 1974) was used in 
this study.  Metal foil resistance ‘self 
temperature compensating strain gauges’ 
were used for the measurement of forces.  
The eyebolt of the tablet press was 
instrumented to measure compression forces 
in the manner of Wray et al (1966).  
 
Measurement of compression forces: The 
eyebolt of the Stokes RB-2 machine was 
instrumented to measure compression forces.  
The instrumentation technique has been 
described previously (Salpekar and 
Augsburger, 1974, 1974).   
 
Compression of tablets: Tablets were 
compressed on a Stokes model RB-2 rotary 
tablet press (Stokes Engineering) which can 
simultaneously monitor compression and 
ejection forces.  Only a single station of the 
tablet press was used to avoid possible tooling 
errors.  The press speed during compression 
was fixed at 24 rpm.  Tablet thickness and 
diameter were measured with a micrometer 
calipers (Tubular Micrometer Co., St. James, 
Minnesota) immediately after 
tabletting.  The temperature and 
relative humidity in the tabletting room 
were maintained at 25 ± 2 0C and 50 
± 10% RH respectively.  The tablet 
press was adjusted to give tablets of 
400 mg weight for the model direct 
compression and hydrochlorothiazide 
tablet formulations.  The weights were 
300 mg for ascorbic acid tablets and 
630 mg for aspirin-paracetamol 
tablets 
A compression force range of 
300-1800 kg was used for 
compressing mixtures containing 
Ditab ® and Fast Flo ®Lactose.  The 
range of force for mixtures containing 
ascorbic acid was 200 -1000 kg.  The 
range of compression forces were 
chosen to provide data over a wide 
range of tabletting conditions.  A 
limitation was also imposed by the 
instrumented tablet press which allows a 
maximum ejection force of 40 kg.  The 
properties of the materials being investigated 
also influenced choice of range of 
compression forces.  The poorly compressible 
ascorbic acid was compressed at a lower 
range of compression force.  On the other 
hand the mixture of Ditab® and Fast Flo 
®Lactose was compressed at the higher range 
of compression force. 
 
Evaluation of tablet hardness: Ten tablets 
were used to determine hardness at each 
compression force on a Pharma Test 
Hardness Tester (Model HT-300, Key 
International Inc., NY) 24 h after the tablets 
had been made.  The HT-300 model 
incorporates an automated push button 
Table 1: Composition of tablet formulations  
Content Quantity 
Model direct compression formulation 
Unmilled dicalcium phosphate (Ditab ®) 1 part 
Hydrous lactose (Fast Flo ®Lactose) 1 part 
Hydrogenated vegetable oils 1-5, 10% w/w 
Hydrochlorothiazide tablets 
Unmilled dicalcium phosphate (Ditab ®) 1 part 
Hydrous lactose (Fast Flo ®Lactose) 1 part 
Hydrochlorothiazide 25 mg 
Sta-Rx®1500 7% w/w 
Hydrogenated vegetable oils 1-5, 10% w/w 
Ascorbic acid tablets 
Ascorbic acid 210 mg 
Compressible sugar (Dipac ®) 40 mg 
Colloidal fumed silicon dioxide (Cab-O-Sil®) 0.5% w/w 
Hydrogenated vegetable oils 5, 10 % w/w 
Aspirin-Paracetamol tablets 
Aspirin granules 345 g 
Paracetamol granules 290 g 
Hydrogenated vegetable oils 5, 10 %w/w 
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activated printer which supplies a reading for 
every tablet tested as the high, low and 
average force values.    
 
Evaluation of friability: The friability loss of 
20 tablets from each batch at each 
compression force was determined on a Van 
der Kamp ‘Roche type’ friabilator (Model No. 
10809, Van-Kel Industries, Inc., NJ, USA).  
Per cent friability was calculated from the 
relationship:  
 
Friability % = WI –WF / WI x 100,  
 
where WI = the initial weight of 20 dedusted 
tablets and WF = the weight of the tablets after 
revolution of the friabilator drum. 
 
Evaluation of disintegration time of tablets: 
Disintegration time of tablets was determined 
by the USP method using the Van der Kamp 
Disintegration Apparatus (Model VK-5, 
Techne, Cambridge Limited, England).  A 0.I N 
HCl was the disintegration medium.  The Van 
der Kamp apparatus has the facility for testing 
six tablets simultaneously.  Two runs in which 
six tablets were tested at the same time were 
made.  The average of the longest 
disintegration time within each group of six 
tablets was recorded.  Disintegration time tests 
were performed for ascorbic acid, aspirin-
paracetamol and hydrochlorothiazide tablets 
only. 
 
Dissolution studies on tablets: The 
dissolution rates of tablets were monitored 
using an automated Van der Kamp 600 six-
spindle dissolution tester (Model VK 600, Van 
Kel Industries, NJ, USA).  The dissolution 
medium was 1000 ml of 0.I N HCl maintained 
at 37 0C.  The stirring rates of the spindles of 
the dissolution apparatus was maintained at 
50 r.p.m.  
Analysis for the drug content of the 
dissolution medium was performed with a UV 
spectrophotometer (Model 25, Beckman 
Instruments, USA.).  Samples were circulated 
to the spectrophotometer via a Manostat 
Cassette pump (Manostat, NY).  The 
absorbance of ascorbic acid, 
hydrochlorothiazide, aspirin and paracetamol 
were measured at 245, 272, 229 and 249 nm 
respectively. Dissolution studies were 
performed on six tablets for each batch of 
tablets.  The dissolution data were plotted as 
percent drug dissolved against time and each 
datum point represents the average of the six. 
 
Statistical analyses of data:  All statistical 
analyses (linear regression, ANOVA, stepwise 
regression) were performed with the aid of 
“canned” software programs written for a 
desktop calculator/computer.  
 
Results and Discussion 
 
The use of hardness in tablet formulation 
development includes determination of the 
basic properties of pure materials, quality 
control specification for in-process validation 
and the study of the effect of formulation and 
manufacturing variables on tablet strength.  
The formulation and manufacturing variable 
include the effects of granule size, moisture 
and lubricants. The effects of the 
hydrogenated vegetable oils on the hardness 
of tablets compressed from a model direct 
compression tablet formulation containing 
equal parts of Ditab ® and Fast Flo® Lactose 
are shown in Fig. 1.  Tablet hardness was 
determined at each compression force level.  
Fig. 1 illustrates that at the 4% w/w 
concentration level, as compression force 
increased tablet hardness also increased.  
Similar results were obtained by other 
workers.  Lerk et al (1974) reported increase in 
the crushing strength of tablets with increase 
in applied force.  The system investigated by 
these workers contained direct compression 
dicalcium phosphate and microcrystalline 
cellulose.  Goh and co-workers (2008) also 
showed that increasing compression force 
resulted in corresponding increase in the 
hardness of tablets prepared from salt, starch 
and fat mixtures. 
In Fig. 2, the effect of Lubritab® 
concentration and mixing time on the hardness 
of tablets made from the model formulation is 
shown. It can be seen that prolonged mixing of 
Lubritab® for 30 min did not influence the 
hardness of the tablets adversely. This is 
typical of results obtained for the 
hydrogenated vegetable oils used in this 
study. It is well known that the hardness of 
tablets depends on the type, amount and 
length of blending of the lubricant. Fig. 3 
showed the effect of the hydrogenated 
vegetable oils on the hardness of ascorbic 
acid tablets at 4 %w/w level of concentration. 
The hardness increased as compression force 
increased. However, the dika fat and stearic 
acid containing ascorbic acid tablets exhibited 
higher hardness values compared to those 
containing Sterotex® and Lubritab®. There was 
no deleterious effect on the hardness of the 
ascorbic acid tablets. 
Fig. 4 showed the effect of Lubritab® 
concentration and blending time on the 
hardness of ascorbic acid tablet formulation.  
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Fig. 1: Typical effect of hydrogenated vegetable oils on the





























Fig. 2: Effect of  Lubritab concentration and mixin g time on the 





























Fig. 4: Typical effect of hydrogenated vegetable oi ls on the hardness of 

























Figure 4 illustrates that prolonged mixing did 
not affect the hardness of the ascorbic acid 
tablets at all concentrations and blending 
times investigated.  
The typical effect of the hydrogenated 
vegetable oils on the hardness of tablets 
compressed from direct compression aspirin-
acetaminophen formulation is shown in Fig 5. 
It can be seen that increasing the 
concentration of dika fat from 5 to 10 %w/w 
resulted in a marginal decrease in tablet 
hardness. This decrease was more 
pronounced at higher compression forces.  
The effect of increasing Lubritab® 
concentration from 5 to 10% w/w, on the 
hardness of tablets compressed from the 
aspirin-paracetamol formulation was opposite 
to that obtained for dika fat.  The hardness of 
tablets containing 10 %w/w Lubritab® was 
higher than that of those containing 5 %w/w 
(Fig. 5).  Dika fat in this regard acted like a 
typical lubricant by decreasing tablet hardness 
at higher concentration while Lubritab® on the 
other hard exhibited auxiliary dry binding 
characteristic (Edward Mendell Co. Inc., USA, 
1982). Tablets containing 10 %w/w Avicel® PH 
102 and PEG 6000 exhibited higher hardness 
values compared to tablets containing 
equivalent concentrations of dika fat or 
Lubritab® indicating potential dry binding 
capability.   
The effect of named excipients on the 
friability of the aspirin-paracetamol tablets was 
evaluated and is shown in Fig. 6. Fig. 6 
showed that friability decreased as 
compression force of the tablets increased. 
Lubritab® containing tablets exhibited friability 
profiles better than those of tablets containing 
Avicel® PH 102 or PEG 6000. 
Fig. 7 showed the effect of Sterotex® 
concentration and mixing time on the friability 
of tablets compressed from the model 
formulation. Fig. 7 showed that at all 
compression force levels, increasing 
compression force caused a corresponding 
decrease in the friability of the tablets. The 
friability tended to a constant regime. Fig 7 
also indicates that prolonged blending of the 
formulations did not adversely affect the 
friability of the tablets containing Sterotex®.  
Fig. 8 showed the effect of 
concentration and blending time of the 
hydrogenated vegetable oils on the 
disintegration time of hydrochlorothiazide 
tablets. Comparatively, the order of decreasing 
disintegration time was Avicel® PH 102 < dika 
fat < PEG 6000 < Lubritab®. However, the 
tablets all met the BP requirement for standard 
tablets, all the tablets disintegrating within 15 
minutes of the test.  
Fig 9 showed the effects of the 
hydrogenated vegetable oils on paracetamol 
dissolution from the aspirin-paracetamol tablet 
formulation.  
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Fig 8: Effect of STX concentration and mixing time on 
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There was no significant difference in the 
dissolution from tablets containing 5 and 10 
%w/w dika fat.  Dissolution from tablets 
containing 10 %w/w PEG 6000 was similar to 
that from tablets containing 10 %w/w 
Lubritab®. Dissolution was more from tablets 
containing 5 %w/w Lubritab® compared to 
those containing 10% w/w of the hydrogenated 
vegetable oil. The T50% and T90% for aspirin 
dissolution from the aspirin-paracetamol 
tablets are shown in Table 2. The T50% and 
T90% for paracetamol dissolution from the 
aspirin-paracetamol dissolution is shown in 
Table 3. The release of either aspirin or 
paracetamol from the aspirin-paracetamool 
tablets met BP (2003) requirements. Neither 
the concentration of the hydrogenated 
vegetable oils nor the prolongation of blending 
time caused delay in the release of the actives 
from the formulations. 
    
Fig 9: Typical effect of excipients on the
disintegration time of tablets compressed from a 




























Fig. 10: Typical effect of excipients on 



































Table 2: The T 50% and T 90% for aspirin 
dissolution from aspirin-paracetamol 
tablets containing 4% named excipients 
and compressed to 6.0 ± 1 kg hardness 
Named excipient T 50% (min) T 90%  (min)  
Dika Fat 6.00 13.50 
Stearolac-S® 5.00 11.50 
Sterotex® 7.00 14.00 
Lubritab® 8.50 24.00 
Stearic acid 13.00 39.00 
 
Table 3: The T 50% and T 90% for paracetamol 
dissolution from aspirin-paracetamol 
tablets containing 4% named excipients 
and compressed to 6.0 ± 1 kg hardness 
Named excipient T 50% (min) T 90% (min) 
Dika Fat 6.50 17.50 
Stearolac-S® 8.00 19.50 
Sterotex®  9.50 22.50 
Lubritab® 11.50 27.50 
Stearic acid 12.00 28.00 
 
Conclusions: The effects of dika fat,  
Lubritab®, Sterotex®, Stearolac-S® and stearic 
acid on the tablet properties of direct 
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compression tablet formulations have been 
determined. Overall, these hydrogenated 
vegetable oils, at 5 - 10 %w/w concentration 
levels, produced desirable hardness and 
friability profiles in the direct compression 
tablet formulations evaluated. All the fats 
produced formulations that passed the USP 23 
requirements of 60% hydrochlorothiazide 
dissolution within 60 minutes Lubritab® was 
found to be a good auxilliary dry binder for 
aspirin-paracetamol tablets. The hydrogenated 
vegetable oils appear to be a good alternative 
to Avicel® PH 102 as auxiliary dry binder in the 





J.O. Onyechi, would like to acknowledge the 
support and assistance of Late Professor 
Ralph Shangraw and Professor Larry 
Augsburger of the School of Pharmacy, 
University of Maryland at Baltimore, 20 North 
Pine Street, Baltimore, MD21201, for their kind 






Goh, S. M., Alten, S., Van Dalen, G., Farr, R. 
S., Gamonpilas, C. and 
Charalambides, M. N. (2008). The 
mechanical properties of model-
compacted tablets. J. Mater. Sci., 43: 
7171 – 7178. 
Lerk, C. F., Bolhuis, G. K. and De Boer, A. H. 
(1974). Comparative evaluation of 
excipients for direct compression II, 
Pharm. Weekbl., 109: 945 – 955. 
Lubritab, Technical Data Sheet, (1982). 
Edward Mendell Co. Inc. 
Onyechi, J. O. (1987). The physico-chemical 
properties of dika fat and its 
application in tabletting. Ph D Thesis, 
School of Postgraduate Studies, 
University of Nigeria, Nsukka. 
Salpekar, A. M. and Augsburger, l. L. (1974) 
Magnesium lauryl sulphate in 
tabletting: Effect on ejection force and 
compressibility. J. Pharm. Sci., 63: 
289 – 293. 
Shangraw, R. F. (1985) In: Modern 
Granulation, Tabletting and Capsule 
Technology, An Institute for Applied 
Pharmaceutical Sciences Publication, 
East Brunswick, N.J. P. E2. 
Wray, P. E., Vincent, J. G., Moller, F. W. and 
Jackson, C. J. (1966). Rotary Tablet 
Machine Instrumentation, Paper 
presented at A.Ph.A. Annual Meeting, 
Industrial Pharmacy Section, Dallas, 
Texas.
 
